Sanguine - About the company
Sanguine is a series B company based in Los Angeles (United States), founded in 2010 by Brian Neman. It operates as a Building a databank of patient-derived data for advanced research. Sanguine has raised $5.53M in funding from Broadoak Capital Partners. The company has 350 active competitors, including 62 funded and 47 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.
Company Details
Building a databank of patient-derived data for advanced research. The company engages patients in biomedical research by delivering transparency throughout the research process. Sanguine collects and de-identifies patient-derived data in the form of biospecimen, and physician and self-reported information. These data are generated and then made available to researchers involved in drug and biomarker research and discovery with leading academic laboratories and companies, such as Vertex.
- Website
- www.sanguinebio.com
- Social
- Email ID
- *****@sanguinebio.com
- Registered Address
- Sherman Oaks, California
Key Metrics
Founded Year
2010
Location
Los Angeles, United States
Stage
Series B
Total Funding
$5.53M in 6 rounds
Latest Funding Round
Investors
Ranked
14th among 350 active competitors
Employee Count
100 as on Jun 30, 2026
Legal entities associated with Sanguine
Sanguine is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SANGUINE BIOSCIENCES, INC CIN: 272874274 , United States, Active | Dec 31, 2009 | - | 89 (As on Dec 31, 2024) | - |
Sign up to download Sanguine's company profile
Sanguine's funding and investors
Sanguine has raised a total funding of $5.53M over 6 rounds. Its first funding round was on Feb 22, 2013. Its latest funding round was a Conventional Debt round on Oct 31, 2023 for $*****. 1 investor participated in its latest round. Sanguine has 11 institutional investors.
Here is the list of recent funding rounds of Sanguine:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 31, 2023 | 1748390 | Conventional Debt | 7240328 | 9065658 | 1608706 | 8365440 |
Jan 09, 2023 | 1737372 | Series B | 6015030 | 9201549 | 4109866 | 8598070 |
Feb 01, 2019 | 9523074 | Grant (prize money) | 9131262 | 9466760 | 9031917 |
Access funding benchmarks and valuations. Sign up today!View details of Sanguine's funding rounds and investors
Sanguine's founders and board of directors
Founder? Claim ProfileThe founders of Sanguine is Brian Neman.
Here are the details of Sanguine's key team members:
- Brian Neman: Co-Founder & CEO of Sanguine. They serve on the board of 1 company.Contact Info: 1 email address
Sanguine's Board of Directors
Sanguine's board has 4 active members. Brian Neman, Randy Socol, Tim Triche and Rudiger Hausherr are independent board members.Here is the list of Sanguine's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 11y 7m | |
xkgxrti | Independent board member | - | Current | 3y 6m |
q{kylat | Independent board member | - | Current | 5y 9m |
rczscjs | Independent board member | - | Current | 3y 9m |
View details of Sanguine's Founder profiles and Board Members
Sanguine's employee count trend
Sanguine has 100 employees as of Jun 26. Here is Sanguine's employee count trend over the years:
Uncover Sanguine's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sanguine's Competitors and alternates
Top competitors of Sanguine include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Sanguine, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd |  Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
3rd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 78/100 | |
5th |  Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
6th |  Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 70/100 | |
7th | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 70/100 | |
8th |  Massive Bio 2014, New York City (United States), Series B | Provider of AI-based clinical trial management tool | $15.6M | 67/100 | |
9th |  TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
10th | _1556172390155.png?devicePixelRatio=2&height=30&width=30){kind=logo} BrightInsight 2017, San Jose (United States), Series C | Provider of digital health solutions for clinical trials | $179M | 64/100 | |
14th | Sanguine 2010, Los Angeles (United States), Series B | Building a databank of patient-derived data for advanced research | $5.53M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Sanguine's competitors? Click here to see the top ones
Sanguine's Investments and acquisitions
Sanguine has made no investments or acquisitions yet.
Reports related to Sanguine
Here is the latest report on Sanguine's sector:
News related to Sanguine
Filter this listMedia has covered Sanguine for a total of 2 events in the last 1 year, 2 of them have been about company updates.
•
•
Sanguine Expands Oncology Biospecimen Offerings Through Strategic Clinic PartnershipsPR Newswire•Sep 16, 2025•Sanguine
•
Sanguine Biosciences Announces the Launch of LeukoCert™ GMP LeukopaksPR Newswire•Nov 04, 2024•Sanguine
•
•
•
•
•
•
•
Metatron (MRNJ) Signs Deal with Lifestyle Company and update on Bitweed™ Crypto Platform with Vaporized Chat Private Security AppSectorpublishingintelligence•Dec 20, 2017•Metatron, Sanguine, ,
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Sanguine
Explore our recently published companies
- Keith Wolfe Casting - Lumberton based, 1996 founded, Unfunded company
- Wood Things - Gretna based, 1996 founded, Unfunded company
- Lilian Jorgenson - Mclean based, 1996 founded, Unfunded company
- Tribology Solutions - Yaphank based, 1996 founded, Unfunded company
- First Fitness - Carrollton based, 1996 founded, Unfunded company
- East Texas Web Design - Lindale based, 1995 founded, Unfunded company
